Point-of-care clinical trials are randomized clinical trials designed to maximize pragmatic design features. The goal is to integrate research into standard care such that the burden of research is minimized for patient and physician, including recruitment, randomization and study visits. When possible, these studies employ Bayesian adaptive methods and data collection through the medical record. Due to the passive and adaptive nature of these trials, a number of unique challenges may arise over the course of a study. In this dissertation, adaptive methodology for Bayesian time-to-event clinical trials is developed and evaluated for studies with limited censoring. Use of a normal approximation to the study parameter likelihood is pro...
University of Minnesota Ph.D. dissertation. August 2010. Major: Biostatistics. Advisor: Bradley P. C...
Because of the high cost and time constraints for clinical trials, researchers often need to determi...
Incorporating historical information into the design and analysis of a new clinical trial has been t...
Background Adaptive designs offer added flexibility in the execution of clinical tri...
Hommel (Biometrical Journal; 45:581–589) proposed a flexible testing procedure for seamless phase II...
Includes bibliographical references (p. 123-128).The process of conducting a pharmaceutical clinical...
A balanced treatment of the theories, methodologies, and design issues involved in clinical trials u...
In this research, two new designs in clinical trials are proposed. The first problem is a new Bayesi...
Abstract Background Bayesian adaptive designs can improve the efficiency of trials, and lead to tria...
Surrogate endpoints are desirable in clinical trials when primary endpoints are costly to obtain, di...
Bayesian adaptive designs are emerging as popular approach to develop adaptive clinical trials. In t...
Abstract. The Bayesian approach is being used increasingly in medical research. The flexibility of t...
This research is dedicated to improve the efficiency of Bayesian adaptive designs for early phase cl...
Background: Adaptive designs offer added flexibility in the execution of clinical trials, including ...
In oncology, toxicity is typically observable shortly after a chemotherapy treatment, whereas effica...
University of Minnesota Ph.D. dissertation. August 2010. Major: Biostatistics. Advisor: Bradley P. C...
Because of the high cost and time constraints for clinical trials, researchers often need to determi...
Incorporating historical information into the design and analysis of a new clinical trial has been t...
Background Adaptive designs offer added flexibility in the execution of clinical tri...
Hommel (Biometrical Journal; 45:581–589) proposed a flexible testing procedure for seamless phase II...
Includes bibliographical references (p. 123-128).The process of conducting a pharmaceutical clinical...
A balanced treatment of the theories, methodologies, and design issues involved in clinical trials u...
In this research, two new designs in clinical trials are proposed. The first problem is a new Bayesi...
Abstract Background Bayesian adaptive designs can improve the efficiency of trials, and lead to tria...
Surrogate endpoints are desirable in clinical trials when primary endpoints are costly to obtain, di...
Bayesian adaptive designs are emerging as popular approach to develop adaptive clinical trials. In t...
Abstract. The Bayesian approach is being used increasingly in medical research. The flexibility of t...
This research is dedicated to improve the efficiency of Bayesian adaptive designs for early phase cl...
Background: Adaptive designs offer added flexibility in the execution of clinical trials, including ...
In oncology, toxicity is typically observable shortly after a chemotherapy treatment, whereas effica...
University of Minnesota Ph.D. dissertation. August 2010. Major: Biostatistics. Advisor: Bradley P. C...
Because of the high cost and time constraints for clinical trials, researchers often need to determi...
Incorporating historical information into the design and analysis of a new clinical trial has been t...